Amaury Jeandrain

In a time where efficiency is a critical mission, innovations such as digital labelling bring solutions to control costs, risks of shortage, drug waste, CO2 emissions, inventories, and more. But do we actually know the impact innovations and decisions have on these indicators? MSD and N-SIDE have worked in the past months on assessing the impact of Digital labelling.

Join us to learn about:

• Digital labelling, its objectives, promises and implications in clinical supply chain
•  How digital labelling impacts costs, waste, sustainability, patients, and more, in clinical trials
• Going further: Processes, regulations, collaboration – How can numbers help change our industry?